Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Home
Investing
Stocks
USA
NASDAQ
Cytek Biosciences Inc (CTKB)
Cytek Biosciences Inc (CTKB) Options

Cytek Biosciences Inc (CTKB)

4.44

0.16

( 3.74% )

Updated: 14:29:13

Cytek Biosciences Inc (CTKB) Options

CTKB Options Flow

Calls

Strike	Bid Price	Ask Price	Last Price	Midpoint	Change	Change %	Volume	OPEN INT	Last Trade
2.50	0.10	4.90	2.14	2.50	0.00	0.00 %	0	5	-
5.00	0.00	0.80	0.10	0.10	0.00	0.00 %	0	59	-
7.50	0.00	0.50	0.30	0.30	0.00	0.00 %	0	17	-
10.00	0.00	4.20	0.10	0.10	0.00	0.00 %	0	1	-

Professional-Grade Tools, for Individual Investors.

Premium

Puts

Strike	Bid Price	Ask Price	Last Price	Midpoint	Change	Change %	Volume	OPEN INT	Last Trade
2.50	0.00	0.05	0.05	0.05	-0.07	-58.33 %	14	51	10:18:21
5.00	0.00	4.80	0.00	0.00	0.00	0.00 %	0	0	-
7.50	0.80	5.50	0.00	3.15	0.00	0.00 %	0	0	-
10.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
ILLRTriller Group Inc	$ 3.3799 (339.46%)	197.05M
ECHOEchoStar Corporation	$ 97.795 (102.73%)	5.81M
AZIAutozi Internet Technology Global Ltd	$ 1.965 (72.37%)	58.69M
NEXRNexera Technologies Ltd	$ 0.9257 (64.57%)	264.12M
IQSTiQSTEL Inc	$ 1.58 (46.30%)	97.91M
ADTXAditxt Inc	$ 0.0027 (-71.58%)	429.63M
RCTRedCloud Holdings PLC	$ 0.2585 (-48.96%)	6.4M
NNOXNano X Imaging Ltd	$ 0.8026 (-48.88%)	15.62M
CRISCuris Inc	$ 0.1969 (-42.12%)	2.41M
DCXDigital Currency X Technology Inc	$ 0.9423 (-41.47%)	6.67M
GDCGD Culture Group Ltd	$ 0.0131 (-39.35%)	797.06M
ADTXAditxt Inc	$ 0.0027 (-71.58%)	429.63M
NEXRNexera Technologies Ltd	$ 0.9257 (64.57%)	264.12M
ILLRTriller Group Inc	$ 3.3799 (339.46%)	197.05M
AALAmerican Airlines Group Inc	$ 17.425 (-0.09%)	162.84M

luckydude777

luckydude777 4 minutes ago

https://www.youtube.com/shorts/O8JiNHcI3jI

cottonmather

cottonmather 5 minutes ago

And that doesn't include all derivaives eom

MomsSpaghetti

MomsSpaghetti 5 minutes ago

Thanks Silver! Been a long ride. Looks like we are taking off. Expect even new comers to get a successful investment from this as well. The rest of the year has so many more catalysts. What a ride.

Cheers!

bubka

bubka 5 minutes ago

Wait, another offering and more dilution? You know how I feel about dilution, but this time I fully support it. Securing strong cash reserves is exactly what a developmental biotech with great trial results needs. You provided a fantastic summary of our current position. Thanks, and go DFTX

Doc328

Doc328 5 minutes ago

The applicant’s claim that who drafted the SAP lacked experience in Alzheimer’s disease trial design and
analysis does not increase the credibility of the findings. The approach for analysing the data was
changed after the end of the study. The applicant openly admits problems with an

ergo sum

ergo sum 5 minutes ago

Bought 3 of these today.

Investor2014

Investor2014 5 minutes ago

Yes and note too that Anavex did not request scientific advise from the CHMP during the application process!!!

jjjjjjjj

jjjjjjjj 6 minutes ago

https://ih.advfn.com/stock-market/USOTC/medical-marijuana-pk-MJNA/trades?_gl=1*1kzkgjy*_gcl_au*MTI1NDQyNTM1NS4xNzMxNjA2NTY3

IT IS DAMN IF IT GOES UP, DAMN IF IT GOES DOWN!which is it??? Let it flow freely . The harder the push, the harder the pullback. ROME WAS NOT BUILT IN ONE DAY. S

WhereDaStocksAt

WhereDaStocksAt 6 minutes ago

Doubled my position at low .01s. If I die, I die lol. Dust or Gold. Willing to double again at .0080s but that's it LOL.

Jcbaby1

Jcbaby1 7 minutes ago

CSAI on watch for possible squeeze play

PickStocks

PickStocks 7 minutes ago

Rumor was JPM hits 300….a distribution happens…just 50.00 for 60 days….but neither happened

SilverTonguedSun

SilverTonguedSun 7 minutes ago

Great take and eloquently put, cheers to the future of this company and the sector as a whole! 🍻

Investor2014

Investor2014 7 minutes ago

No surprises to me, except that Anavex had applied for approval only for SIGMAR1 wild type patients.

The application relied on one pivotal trial that failed its primary objective. Claimed positive endpoint results were considered non-confirmatory because of the trial failure, lack of

santafe2

santafe2 7 minutes ago

I've followed Jeremy Grantham since the early 1990s. He's sometimes referred to as a perma-bear but he's simply a more conservative investor. He's also called the three most significant market downturns in the last 40 years. He's also calling this one; the AI bubble. Since I began taking this bubble

Trum

Trum 8 minutes ago

SCAM... proven SCAM... pump and dump winding down... maybe get back in at .0001-3 range and hold for a year +... maybe ...

Whalatane

Whalatane 8 minutes ago

Thx ...but its more confidence in the hedge funds backing UNCY .
They're in it to make as much $ as fast as possible ...are they at about 40% of ownership ?? will chk .
They will be all about licensing or out right sale ...although I expect them to wait to see if TDAPA is extended ou

doccjc

doccjc 8 minutes ago

All these share price predictions post IDE approval seem fairly low imo . Let’s not forget IsoPet nearing profitability , India and other future international trials ? And PrecisionGel licensing potential. Not a one trick pony . IDE approval should get the ball rolling

i_like_bb_stock

i_like_bb_stock 9 minutes ago

Overwatch

Overwatch 9 minutes ago

If I didn't like a ticker the last thing I would do is spend the entire f"n day here posting... Cover your short positions assholes...

MarketMindset

MarketMindset 10 minutes ago

Kobrea Confirms Copper-Gold Porphyry System at El Perdido – Core Still Untested, System Strengthening at Depth

Posted on behalf of Kobrea Copper Corp. - First drill campaign. Porphyry system confirmed. Most of the target still untested.

Kobrea's inaugural program at El

Overwatch

Overwatch 11 minutes ago

This ticker needs a GME F YOU...

quigley24

quigley24 11 minutes ago

when the audit comes out......it will be WORTH THE WAIT

Jcbaby1

Jcbaby1 11 minutes ago

CSAI about to make its move

Trooperstocks

Trooperstocks 11 minutes ago

$ILLR Triller Group (Nasdaq: ILLR): The Reverse Split Is Not the Story — Execution, Recapitalization and Shareholder Value Are
June 25 2026

Following today’s announcement by Triller Group Inc. (Nasdaq: ILLR) regarding its SPCX-linked strategic treasury transaction, Wing-Fai Ng

Cambreau

Cambreau 11 minutes ago

Been 45 days since shares have been updated. Wonder how close this is to A.S. being maxed out ?

Cytek Biosciences

Royal Bank of Canada

1.375% 23mar2026 1.375% ...

Spark New Zealand

Delayed Upgrade Clock

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

ADVFN

Already have an account? Sign in

Don't have an account? Sign up

By registering, I confirm I have read, understand, and agree to ADVFN's Terms and Conditions and that I am a private investor.